- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platinum-sensitive Urothelial Bladder Cancer
Total 1944 results
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder CancerUnited States
-
Infinity Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedSolid Tumor | Bladder Cancer | Advanced Cancer | Urothelial CarcinomaFrance, Spain, United States, Italy, Czechia, Poland, Serbia
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioActive, not recruitingMuscle-invasive Bladder CancerCanada
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)China
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...European Institute of Oncology; ASST Santi Paolo e CarloRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Italy
-
Gilead SciencesMerck KGaA, Darmstadt, GermanyRecruitingMetastatic Urothelial CancerItaly, United States, Korea, Republic of, Spain, Greece, France, Germany, United Kingdom, Turkey
-
Matthew GalskyBristol-Myers Squibb; Hoosier Cancer Research NetworkCompletedMetastatic Urothelial CancerUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial CancerUnited States, Canada
-
Nucleix Ltd.CompletedBladder CancerNetherlands, Israel, Germany, Spain
-
University of FloridaRecruitingUrothelial Carcinoma BladderUnited States
-
Erasmus Medical CenterRecruitingBladder Cancer | Urothelial Carcinoma | Hematuria | Urothelial NeoplasmNetherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsNot yet recruiting
-
Jens NielsenGöteborg UniversityCompletedBladder CancerSweden
-
Noah Hahn, M.D.Novartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedBladder CancerUnited States
-
University of Michigan Rogel Cancer CenterPfizerTerminatedBladder CancerUnited States
-
Bobbie Jo Rimel, MDRecruitingRecurrent Ovarian Cancer | Platinum-sensitive Ovarian CancerUnited States
-
Abdelwahab HashemUnknownTrauma | Bladder Cancer | Injuries | Bladder Urothelial Carcinoma | Perforation of Bladder | Recurrence Tumor | Resection Margin | Seeding, NeoplasmEgypt
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Lawrence FongCellSight Technologies, Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
University of MichiganPfizerTerminatedBladder Cancer | Urothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
National Cancer Institute (NCI)RecruitingUrogenital Neoplasms | Bladder Cancer | Urothelial Cancer | Genitourinary Cancer | Urogenital CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingUrothelial Carcinoma | Non-Invasive Bladder Urothelial CarcinomaUnited States
-
Hoffmann-La RocheRecruitingUrothelial CancerKorea, Republic of, United States, Brazil, China, France, Germany, Mexico, Poland, Denmark, Italy, Turkey, Greece, Spain, United Kingdom, Australia
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerUnited States, France, Germany, United Kingdom, Belgium, Taiwan, Spain, Israel, India, Romania, Korea, Republic of, Russian Federation, Turkey, Austria, Moldova, Republic of
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerKorea, Republic of, United States, Italy, Spain, Japan, United Kingdom, Belgium, Israel, China, Austria, France, Canada, Taiwan, Turkey, Germany, Russian Federation, Bulgaria, Poland, Greece, Brazil, Netherlands, Australia, Argentina, Mexic... and more
-
Monika Joshi, MDAstraZenecaActive, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
The First Hospital of Jilin UniversityNot yet recruitingPlatinum-sensitive Relapsed Ovarian Cancer
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of
-
Brigham and Women's HospitalNot yet recruitingMuscle Invasive Bladder Urothelial CarcinomaUnited States
-
Dr Anders UllénCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
PfizerTerminatedUrinary Bladder Neoplasms | Bladder Cancer | Urothelial Carcinoma | Bladder TumorsCanada
-
Aduro Biotech, Inc.Incyte CorporationTerminatedPlatinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal CancerUnited States, Canada
-
Tianjin Medical University Second HospitalRecruitingBladder Urothelial CarcinomaChina
-
National Cancer Institute (NCI)RecruitingUrogenital Neoplasms | Bladder Cancer | Urothelial Cancer | Genitourinary Cancer | Urogenital CancerUnited States
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
Chinese University of Hong KongRecruitingUpper Tract Urothelial CancerHong Kong
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Guarionex J. DecastroSanofiActive, not recruitingUrothelial Carcinoma of the Urinary BladderUnited States
-
Ectin Research ABNot yet recruitingMetastatic Urothelial CancerSweden
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
University Hospital, GhentCompletedMetastatic Urothelial CancerBelgium
-
AdaptimmuneCompletedMelanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial CarcinomaUnited States, Canada, Spain
-
Noah Hahn, M.D.AstraZeneca; Hoosier Cancer Research NetworkRecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Malignant Ovarian Endometrioid Tumor | Ovarian High Grade Serous Adenocarcinoma | Platinum-Sensitive Ovarian Carcinoma | Fallopian Tube High Grade Serous Adenocarcinoma and other conditionsUnited States